alanine has been researched along with Thrombophilia in 6 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Thrombophilia: A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, should some hospitalized patients have dosage escalation to intermediate dose? Should some be considered for full-dose anticoagulation without a measurable thromboembolic event and how should that anticoagulation be monitored? Should patients receive postdischarge anticoagulation and with what medication and for how long? What thrombotic issues are related to the various medications being used to treat this coagulopathy? Is antiphospholipid antibody part of this syndrome? What is the significance of isolated ischemic stroke and limb ischemia in this disorder and how does this interface with the rest of the clinical and laboratory features of this disorder? The aims of this article are to explore these questions and interpret the available data based on the current evidence." | 2.72 | COVID-19 and Its Implications for Thrombosis and Anticoagulation. ( Berkman, SA; Tapson, VF, 2021) |
| "Magnetic resonance imaging showed brain infarction; therefore detailed diagnostic evaluation of thrombophilia markers and genetic testing were performed." | 1.40 | MTHFR C677T and prothrombin G20210A mutations in a woman from Dalmatia with silent brain infarction. . ( Ivica, N; Pintarić, I; Titlić, M, 2014) |
| "The prevalence of thrombophilia is not increased in women with severe OHSS." | 1.32 | Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. ( Balasch, J; Carmona, F; Fábregues, F; Ordinas, A; Reverter, JC; Tàssies, D, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Di Perri, G | 1 |
| Berkman, SA | 1 |
| Tapson, VF | 1 |
| Ivica, N | 1 |
| Pintarić, I | 1 |
| Titlić, M | 1 |
| Diz-Kucukkaya, R | 1 |
| Hancer, VS | 1 |
| Artim-Esen, B | 1 |
| Pekcelen, Y | 1 |
| Inanc, M | 1 |
| Djordjevic, V | 1 |
| Mitic, G | 1 |
| Pruner, I | 1 |
| Kovac, M | 1 |
| Radojkovic, D | 1 |
| Fábregues, F | 1 |
| Tàssies, D | 1 |
| Reverter, JC | 1 |
| Carmona, F | 1 |
| Ordinas, A | 1 |
| Balasch, J | 1 |
2 reviews available for alanine and Thrombophilia
| Article | Year |
|---|---|
COVID-19 and Its Implications for Thrombosis and Anticoagulation.
Topics: Adenosine Monophosphate; Alanine; Ambulatory Care; Antibodies, Antiphospholipid; Antibodies, Monoclo | 2021 |
The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome.
Topics: Alanine; Amino Acid Substitution; Antiphospholipid Syndrome; Factor V; Glycine; Humans; Mutation; Pr | 2010 |
4 other studies available for alanine and Thrombophilia
| Article | Year |
|---|---|
The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection
Topics: Adenosine Monophosphate; Alanine; Anticoagulants; Antiviral Agents; Biomarkers; Coronavirus Infectio | 2020 |
MTHFR C677T and prothrombin G20210A mutations in a woman from Dalmatia with silent brain infarction. .
Topics: Alanine; Anticoagulants; Biomarkers; Brain Infarction; Croatia; Cysteine; Female; Glycine; Heterozyg | 2014 |
Are thrombophilia more multifactorial than we thought: report of mosaicism for FII G20210A and novel FII T20061C gene variants.
Topics: Alanine; Biomarkers; Cysteine; Female; Genotype; Glycine; Humans; Hypertension, Pulmonary; Middle Ag | 2012 |
Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Topics: Adult; Alanine; Case-Control Studies; Cost-Benefit Analysis; Factor V; Female; Genetic Testing; Glyc | 2004 |